Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals is conducting a phase 2/3 study in warm autoimmune hemolytic anemia and a phase 1/2 study in immune thrombocytopenia. We will have materials on these ongoing trials (brochures and digital displays on flat screen monitors) as well as materials on disease state awareness to highlight the unmet medical needs for both disease states.